| Placebo | Antithrombin |
---|---|---|
Number of patients (n) | 16 | 17 |
Age (years) | 56 ± 17 | 51 ± 19 |
Height (cm) | 175 ± 4 | 169 ± 9 |
Weight (kg) | 80.7 ± 22.5 | 75.9 ± 22.4 |
4-day survival rate (n) | 16 | 16 |
28-day survival rate (n) | 11 | 12 |
Acute Pathophysiology and Chronic Health Evaluation II score | 52 ± 9.5 | 53 ± 12.6 |
Low-molecular-weight heparin at inclusion (IU/day) | 6042 ± 1982 | 6388 ± 2205 |